Drugs / Perforomist
last change Jan 2016 re-read 3 minutes ago

Perforomist

Developed for
chronic obstructive pulmonary disease
Investigated by
Dey

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) PERFOROMIST — 2007-05-11 fda.gov ↗

Trials 1

today
US approved 2007
NCT01488019 · Ph 4
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01488019 Mar 2012 → Jan 2016 chronic obstructive pulmonary disease Dey Completed Met primary

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Perforomist ClinicalTrials.gov intervention name — accepted as the source's own label NCT01488019 ↗